IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $291,365 | -71.9% | 30,256 | -69.3% | 0.00% | -100.0% |
| Q1 2023 | $1,035,641 | -75.9% | 98,445 | -71.6% | 0.00% | -71.4% |
| Q4 2022 | $4,289,530 | -17.4% | 346,209 | -31.0% | 0.01% | -22.2% |
| Q3 2022 | $5,196,000 | +1673.4% | 501,577 | +1876.6% | 0.01% | – |
| Q2 2022 | $293,000 | -35.0% | 25,376 | -27.5% | 0.00% | -100.0% |
| Q1 2022 | $451,000 | -65.8% | 34,994 | -69.1% | 0.00% | -50.0% |
| Q4 2021 | $1,320,000 | -45.1% | 113,234 | -38.5% | 0.00% | -50.0% |
| Q3 2021 | $2,404,000 | +1.5% | 184,074 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $2,369,000 | +116.1% | 184,074 | +87.7% | 0.00% | +200.0% |
| Q1 2021 | $1,096,000 | -56.8% | 98,045 | -56.0% | 0.00% | -50.0% |
| Q4 2020 | $2,536,000 | +152.8% | 222,666 | +106.5% | 0.00% | 0.0% |
| Q3 2020 | $1,003,000 | – | 107,811 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $172,422,800 | 22.05% |
| 13D Management LLC | 533,562 | $5,613,073 | 2.85% |
| Quantedge Capital Pte Ltd | 541,200 | $5,693,424 | 2.22% |
| Price Jennifer C. | 520,000 | $5,470,400 | 1.74% |
| Tamarack Advisers, LP | 210,000 | $2,209,200 | 0.81% |
| Intrinsic Value Partners, LLC | 51,605 | $542,885 | 0.73% |
| Brown Capital Management | 3,933,933 | $41,384,975 | 0.62% |
| Old West Investment Management, LLC | 75,219 | $791,303 | 0.43% |
| EMC Capital Management | 43,315 | $456 | 0.38% |
| Hillsdale Investment Management Inc. | 420,617 | $4,424,891 | 0.38% |